Stock Events

Stock Events

Regeneron Pharmaceuticals (REGN.VI) Q2 2021 Keputusan kewangan

REGN.VI
6MayDisahkan
Q3 2020
Q4 2020
Q1 2021
Q2 2021
4.83
5.95
7.07
8.19

Butiran

EPS dijangka
7.018242000000001
EPS sebenar
8.194854000000001
EPS mengejut
1.18
Peratus kejutan
+16.77%

Deskripsi

Regeneron Pharmaceuticals (REGN.VI) telah melaporkan pendapatan sebanyak 8.194854000000001 sesaham untuk Q2 2021.

0 Comments

Kongsi pendapat anda